Menopause, metabolism & midlife weight gain
Menopause gets blamed on hormones — and that is partly fair. Estrogen and progesterone change. Sleep can get worse. Body composition can shift. Weight may become harder to manage even when a woman feels like she is eating the same, moving the same, and doing all the right things. But hormones are not the whole story. A growing part of the conversation is metabolic health — especially how well the body uses fuel at the cellular level. That is where MOTS-c has started getting attention.
Quick answer: what is MOTS-c?
MOTS-c is a small peptide made from mitochondrial DNA. Mitochondria are often described as the energy-producing parts of the cell. Early research suggests MOTS-c may influence glucose use, insulin sensitivity, AMPK signaling, fat metabolism, and mitochondrial function — but it is still an emerging area of study, not a proven menopause treatment.
Why menopause can feel like a metabolic shift
Many women describe menopause as if their body suddenly changed the rules. The same meals hit differently. Belly fat becomes more stubborn. Energy dips. Recovery slows down. Brain fog shows up at the worst times. That does not mean the body is broken — it may mean the body has become less metabolically flexible. Metabolic flexibility is the body's ability to switch between using glucose and fat for fuel. When insulin signaling gets worse, glucose can stay higher in the bloodstream while cells still act under-fueled.
Where MOTS-c fits in
MOTS-c appears to communicate with key metabolic pathways including AMPK — one of the body's energy-sensing systems. In animal and laboratory research, MOTS-c has been associated with improved insulin sensitivity, better glucose uptake, and protection against weight gain. One menopause-related metabolic dysfunction study found MOTS-c reduced ovariectomy-induced weight gain, insulin resistance, fat mass, and inflammatory response. See also this 2022 review on MOTS-c and mitochondrial-derived peptide research.
Hormones still matter — but metabolism matters too
Hormone replacement therapy can be helpful for some women — that decision belongs between a woman and a qualified medical provider. But replacing or supporting hormones does not automatically fix poor insulin sensitivity, low muscle mass, poor sleep, high visceral fat, or mitochondrial dysfunction. A more complete menopause conversation should include: insulin sensitivity, muscle mass, visceral fat, sleep quality, and mitochondrial health.
What we should be careful about
MOTS-c is not an FDA-approved menopause treatment. Human therapeutic evidence is still limited, and several peptide-related substances including MOTS-c are under ongoing FDA peptide compounding review. "Interesting mechanism" is not the same as proven safety, dosing, or long-term outcomes in humans. For now, MOTS-c should be viewed as an emerging metabolic-health topic — not a magic fix.
A better way to think about menopause support
The better question is not "what one thing fixes menopause?" — it is "what is blocking this woman's metabolism from working the way it should?" For one woman, that may be low muscle mass. For another, poor sleep, insulin resistance, inflammation, under-eating protein, thyroid issues, stress, or a combination. That is why testing, body composition, history, and real-world symptoms matter. We usually start with a free 15-minute Discovery Call to see whether the right path is labs, clinically guided weight loss, peptides, body contouring, or a combination. For more on visceral fat specifically, read What Visceral Fat Is Really Doing to You.
Book a free 15-minute call with Mike →